CLINICAL_TRIALS
trial_result
· 2010-11-22
Clinical Trial Update: Fesoterodine "add-on" Male Overactive Bladder Study [Phase 3]
Summary
Phase 3 trial update for fesoterodine as add-on therapy in men with overactive bladder. The study is completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Overactive Bladder Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2010-11-22